Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation and Optimization of the Clinical Accuracy of Hybribio's 14 High-Risk HPV with 16/18 Genotyping Assay within the VALGENT-3 Framework
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 58, Issue 6, Pages -
Publisher
American Society for Microbiology
Online
2020-04-06
DOI
10.1128/jcm.00234-20
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A direct comparison of four high‐risk human papillomavirus tests versus the cobas test: Detecting CIN2+ in low‐resource settings
- (2019) Peng Xue et al. JOURNAL OF MEDICAL VIROLOGY
- Using the VALGENT-3 framework to assess the clinical and analytical performance of the RIATOL qPCR HPV genotyping assay
- (2019) I. Benoy et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical performance of the HPV-Risk assay on cervical samples in SurePath medium using the VALGENT-4 panel
- (2019) D.A.M. Heideman et al. JOURNAL OF CLINICAL VIROLOGY
- Continuing global improvement in human papillomavirus DNA genotyping services: The 2013 and 2014 HPV LabNet international proficiency studies
- (2018) Carina Eklund et al. JOURNAL OF CLINICAL VIROLOGY
- Assessment of the Roche Linear Array HPV Genotyping Test within the VALGENT framework
- (2018) Lan Xu et al. JOURNAL OF CLINICAL VIROLOGY
- Clinical Evaluation of INNO-LiPA HPV Genotyping EXTRA II Assay Using the VALGENT Framework
- (2018) Lan Xu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Clinical and analytical evaluation of the Anyplex II HPV HR Detection assay within the VALGENT-3 framework
- (2018) Anja Oštrbenk et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Validation of EUROArray HPV test using the VALGENT framework
- (2018) Jessica Viti et al. JOURNAL OF CLINICAL VIROLOGY
- The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium
- (2018) Jesper Bonde et al. JOURNAL OF CLINICAL VIROLOGY
- Evaluation of the Clinical Performance of the HPV-Risk Assay Using the VALGENT-3 Panel
- (2017) N. J. Polman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests)
- (2016) Kate Cuschieri et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework
- (2016) I. Heard et al. JOURNAL OF CLINICAL VIROLOGY
- VALGENT: A protocol for clinical validation of human papillomavirus assays
- (2016) Marc Arbyn et al. JOURNAL OF CLINICAL VIROLOGY
- Commercially available molecular tests for human papillomaviruses (HPV): 2015 update
- (2016) Mario Poljak et al. JOURNAL OF CLINICAL VIROLOGY
- Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening?
- (2015) M. Arbyn et al. CLINICAL MICROBIOLOGY AND INFECTION
- Clinical and Analytical Performance of the Onclarity HPV Assay Using the VALGENT Framework
- (2015) K. Cuschieri et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Clinical Evaluation of a GP5+/6+-Based Luminex Assay Having Full High-Risk Human Papillomavirus Genotyping Capability and an Internal Control
- (2014) D. T. Geraets et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Viral Load of High-Risk Human Papillomaviruses as Reliable Clinical Predictor for the Presence of Cervical Lesions
- (2013) M. Schmitt et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Multiple Human Papillomavirus Infections with High Viral Loads Are Associated with Cervical Lesions but Do Not Differentiate Grades of Cervical Abnormalities
- (2013) M. Schmitt et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
- (2013) Guglielmo Ronco et al. LANCET
- Evaluation of the detection of 14 high-risk human papillomaviruses with HPV 16 and HPV 18 genotyping for cervical cancer screening
- (2013) MEI-LU BIAN et al. Experimental and Therapeutic Medicine
- Prevalence and viral load of 51 genital human papillomavirus types and three subtypes
- (2012) Markus Schmitt et al. INTERNATIONAL JOURNAL OF CANCER
- Evidence Regarding Human Papillomavirus Testing in Secondary Prevention of Cervical Cancer
- (2012) Marc Arbyn et al. VACCINE
- Comparison of Clinical and Analytical Performance of the Abbott RealTime High Risk HPV Test to the Performance of Hybrid Capture 2 in Population-Based Cervical Cancer Screening
- (2011) M. Poljak et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Commercially available assays for multiplex detection of alpha human papillomaviruses
- (2010) Mario Poljak et al. Expert Review of Anti-Infective Therapy
- Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older
- (2008) Chris J.L.M. Meijer et al. INTERNATIONAL JOURNAL OF CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now